Prosecution Insights
Last updated: August 18, 2026

Examiner: HANEY, AMANDA MARIE

Tech Center 1600 • Art Units: 1634 1682 1693

This examiner grants 36% of resolved cases

Performance Statistics

36.5%
Allow Rate
-23.5% vs TC avg
777
Total Applications
+44.5%
Interview Lift
1270
Avg Prosecution Days
Based on 712 resolved cases, 2023–2026

Rejection Statute Breakdown

23.3%
§101 Eligibility
10.2%
§102 Novelty
23.2%
§103 Obviousness
32.8%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17005858 B-CELL MATURATION COMPLEX CAR T CONSTRUCT AND PRIMERS Non-Final OA Janssen Biotech, Inc.
17612610 PROTOCOL FOR DETECTING INTERACTIONS WITHIN ONE OR MORE DNA MOLECULES WITHIN A CELL Non-Final OA Oxford Nanopore Technologies PLC
17433542 MULTIPLEXED SIGNAL AMPLIFICATION METHODS USING ENZYMATIC BASED CHEMICAL DEPOSITION Final Rejection The Board of Trustees of the Leland Stanford Junior University
17787499 PRIMERS FOR DETECTING TRACE AMOUNT OF RARE SINGLE- NUCLEOTIDE VARIANT AND METHOD FOR SPECIFICALLY AND SENSITIVELY DETECTING TRACE AMOUNT OF RARE SINGLE-NUCLEOTIDE VARIANT BY USING SAME Final Rejection KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION
18548972 ISOTHERMAL AMPLIFICATION OF PATHOGENS Non-Final OA BECTON, DICKINSON AND COMPANY
18422276 METHOD AND SYSTEM FOR RISK ASSESSMENT OF AUTISM SPECTRUM DISORDER IN A SUBJECT Non-Final OA Tata Consultancy Services Limited
17047006 NON-INVASIVE DETECTION OF RESPONSE TO IMMUNOTHERAPY Final Rejection The Johns Hopkins University
16809496 METHOD OF IDENTIFYING RISK FOR AUTISM Final Rejection The Johns Hopkins University
18560569 NOVEL PREDICTIVE BIOMARKERS FOR SECONDARY AUTOIMMUNITY AFTER LYMPHOCYTE DEPLETING THERAPY Non-Final OA GENZYME CORPORATION
17905129 METHODS OF USING A MULTI-ANALYTE APPROACH FOR DIAGNOSIS AND STAGING A DISEASE Non-Final OA THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
18346973 Quantum Dot-Nucleotide Based Ratiometric Fluorescent Molecular Beacon for Quantitative CRISPR/Cas Activity Detection Non-Final OA The Government of the United States of America, as represented by the Secretary of the Navy
18366149 MRNA ANALYSIS USING RESTRICTION ENZYMES Non-Final OA Waters Technologies Corporation
17445284 METHODS, COMPOSITIONS, AND DEVICES FOR SOLID-STATE SYNTEHSIS OF EXPANDABLE POLYMERS FO RUSE IN SINGLE MOLECULE SEQUENCINGS Final Rejection Roche Sequencing Solutions, Inc.
18038915 METHOD FOR DETECTING SEVERITY OF ATOPIC DERMATITIS Final Rejection KAO CORPORATION
17904348 NUCLEIC ACID PROBES Final Rejection Agency for Science, Technology and Research
17344792 METHOD FOR ISOLATING POLY(A) NUCLEIC ACIDS Non-Final OA QIAGEN GmbH

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month